Clinical, endocrine, and metabolic evaluations were performed in seven institutionalized patients with tuberous sclerosis. Several of these patients had evidence of abnormal pituitary adrenal function; two had thyroid disorders; five had abnormal responses to intravenous glucose tolerance tests; and all seven patients had high serum alkaline phosphatase levels. Skeletal surveys disclosed multiple skeletal defects including abnormalities in the size of the sella turcica. These findings indicate that endocrine and metabolic dysfunction is a frequent component of tuberous sclerosis and may be evidenced by a variety of manifestations.
Sareen CK, Ruvalcaba RHA, Scotvold MJ, Mahoney CP, Kelley VC. Tuberous Sclerosis: Clinical, Endocrine, and Metabolic Studies. Am J Dis Child. 1972;123(1):34–39. doi:10.1001/archpedi.1972.02110070084010
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: